UnitedHealth Group Incorporated (NYSE:UNH) Position Trimmed by Keeler Thomas Management LLC

Key Points

• Keeler Thomas Management LLC reduced its stake in UnitedHealth Group by 48.5%, owning 5,736 shares worth $3,004,000, making it the firm's 20th largest position.
• UnitedHealth Group reported $4.08 EPS for the last quarter, missing estimates of $4.45, while revenue reached $111.62 billion, slightly below the expected $111.75 billion.
• The company recently increased its quarterly dividend to $2.21 per share, reflecting a payout ratio of 38.30% and an annual yield of 3.6%.

Keeler Thomas Management LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 48.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,736 shares of the healthcare conglomerate's stock after selling 5,395 shares during the period. UnitedHealth Group makes up 1.5% of Keeler Thomas Management LLC's portfolio, making the stock its 20th biggest position. Keeler Thomas Management LLC's holdings in UnitedHealth Group were worth $3,004,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Capital International Investors raised its stake in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the period. Northern Trust Corp boosted its stake in shares of UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the period. Finally, GAMMA Investing LLC boosted its position in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In related news, Director Kristen Gil purchased 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, CFO John F. Rex acquired 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the purchase, the chief financial officer directly owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last ninety days. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

UNH stock traded down $1.37 during mid-day trading on Thursday, reaching $244.42. The company had a trading volume of 11,331,473 shares, compared to its average volume of 18,403,832. The stock's 50-day simple moving average is $292.78 and its two-hundred day simple moving average is $408.71. The stock has a market capitalization of $221.72 billion, a P/E ratio of 10.59, a P/E/G ratio of 1.59 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the company posted $6.80 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 3.6%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of several recent analyst reports. Oppenheimer cut their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Truist Financial dropped their price target on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Finally, Erste Group Bank cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $366.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.